The estimated Net Worth of Bradford S Goodwin is at least $130 mil dollars as of 9 August 2007. Bradford Goodwin owns over 10,000 units of Rigel Pharmaceuticals stock worth over $129,700 and over the last 19 years Bradford sold RIGL stock worth over $0.
Bradford has made over 1 trades of the Rigel Pharmaceuticals stock since 2007, according to the Form 4 filled with the SEC. Most recently Bradford bought 10,000 units of RIGL stock worth $99,300 on 9 August 2007.
The largest trade Bradford's ever made was buying 10,000 units of Rigel Pharmaceuticals stock on 9 August 2007 worth over $99,300. On average, Bradford trades about 385 units every 0 days since 2006. As of 9 August 2007 Bradford still owns at least 10,000 units of Rigel Pharmaceuticals stock.
You can see the complete history of Bradford Goodwin stock trades at the bottom of the page.
Bradford's mailing address filed with the SEC is C/O RIGEL PHARMACEUTICALS, INC., 1180 VETERANS BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke y Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: